Evidence for the heterotetrameric structure of the adenosine A2A–dopamine D2 receptor complex
V Casadó-Anguera, J Bonaventura… - Biochemical Society …, 2016 - portlandpress.com
Heteromers of G-protein-coupled receptors (GPCRs) have emerged as potential novel
targets for drug development. Accumulating evidence indicates that GPCRs can form …
targets for drug development. Accumulating evidence indicates that GPCRs can form …
Evidence for the heterotetrameric structure of the adenosine A2A-dopamine D2 receptor complex
V Casadó-Anguera, J Bonaventura… - Biochemical …, 2016 - pubmed.ncbi.nlm.nih.gov
Heteromers of G-protein-coupled receptors (GPCRs) have emerged as potential novel
targets for drug development. Accumulating evidence indicates that GPCRs can form …
targets for drug development. Accumulating evidence indicates that GPCRs can form …
Evidence for the heterotetrameric structure of the adenosine A2A-dopamine D2 receptor complex.
V Casadó-Anguera, J Bonaventura… - Biochemical Society …, 2016 - europepmc.org
Heteromers of G-protein-coupled receptors (GPCRs) have emerged as potential novel
targets for drug development. Accumulating evidence indicates that GPCRs can form …
targets for drug development. Accumulating evidence indicates that GPCRs can form …
Evidence for the heterotetrameric structure of the adenosine A2A–dopamine D2 receptor complex.
V Casadó-Anguera, J Bonaventura… - Biochemical Society …, 2016 - search.ebscohost.com
Heteromers of G-protein-coupled receptors (GPCRs) have emerged as potential novel
targets for drug development. Accumulating evidence indicates that GPCRs can form …
targets for drug development. Accumulating evidence indicates that GPCRs can form …